0
0

Cart (0)

Home > Isotope Labelled Standards > Tepotinib

Tepotinib - Isotope Labelled Standards
Wishlist
Select options

Tepotinib 13CD3

  • CAT NUMBER DCTI-A-300
  • CAS NUMBER NA
  • MOLECULAR FORMULA C28H25D3N6O2
  • MOLECULAR WEIGHT 496.59
Select options
Wishlist
References
FAQ's

References

  1. Dorsch, Dieter; Stieber, Frank; Schadt, Oliver; Blaukat, Andree, Pyridazinone Derivates, Merck Patent G.m.b.H., Germany, EP2164843B1, October 29, 2014
  2. Method Development and Validation for the Estimation of Tepotinib in Pharmaceutical Dosage Forms by RP-HPLC, December 2022 Vol.:26, Issue:1

Frequently Asked Questions

Analytical methods, such as high-performance liquid chromatography (HPLC), are commonly used to detect and quantify impurities in Tepotinib.

Yes, impurities in Tepotinib can impact patient safety. Depending on their nature and concentration, contaminants can cause adverse effects or reduce the efficacy of the medication.

It is essential to synthesize impurities of Tepotinib to accurately identify, characterize, and establish their permissible limits within the drug product.

Tepotinib impurities are stored at a controlled room temperature between 2-8 °C or as indicated on the Certificate of Analysis (CoA).

Note: Products protected by valid patents by a manufacturer are not offered for sale in countries having patent protection. The sale of such products constitutes a patent infringement, and its liability is at the buyer's risk.

Back to Top
Product has been added to your cart